A wide spectrum of neonatal and pediatric liver diseases can be successfully treated by liver Transplantation (LT). During the last sixty years, refined diagnostic and surgical techniques, improvements in perioperative care, and the advent of better immunosuppressive medications have established LT as a viable treatment option for acute and chronic liver failure in children. As clinical and laboratory findings of LT complications are often nonspecific, imaging tests play a major role in both diagnosis and guidance of therapeutic interventions. In this article, we wanted to emphasize the potential role of gadoxetic acid-enhanced MRI in the evaluation of liver transplant grafts in the pediatric population.We included seven pediatric patients who underwent gadotexic acid-enhanced MRI with different operative procedures.
too. Furthermore, using this specific Contrast Media (CM), we can detect global and segmental parenchymal dysfunction due its unique pharmacokinetic properties [6] . This CM is used routinely in adults and off-label in children, for the work-up of focal liver lesions, diffuse liver diseases and hepatobiliary disorders, including the evaluation of LT grafts [7] . Through the following case series, we illustrate the use of gadoxetic acid enhanced-MRI in a variety of post-op LT patients with a broad spectrum of complications demonstrating its morphologic and functional properties.
Case 1
A 14-year-old boy with known Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) was brought to the ED with abdominal pain. Laboratory tests demonstrated severe elevation of cholestatic liver function parameters. MRCP performed preoperatively showed a "string of pearls", i.e. irregularity of the bile duct caliber, very characteristic of PSC (Figure 1a ). Gadoxetic acid enhanced-MRI showed diminished uptake and absent excretion of CM in the liver on HBP images consistent with end-stage chronic liver disease (Figure 1b,c) . Soon thereafter, he received a whole liver graft, i.e. orthotopic LT. Fivemonths post-op MRI showed good uptake and timely excretion of Submit your Manuscript | www.austinpublishinggroup.com CM in the HBP (Figure 1d ,e). Laboratory tests at both time points also confirmed normal liver function.
Case 2
A 7-month-old infant was brought to the Emergency Department (ED) with confusion. Physical examination was unremarkable except for signs of encephalopathy. Liver enzymes, including ammonia level, were elevated indicating acute liver failure. A living-related donor LT, for acute hepatic necrosis, was performed immediately, using the mother's left lobe as the graft. Postoperatively, the patient was placed on ursodeoxycholic acid, tacrolimus and cortisone. The patient was fine until 10 years later, when cortisone therapy was discontinuedto reduce its long-term side effects. US and subsequent abdominal CT were performed for mild cholestasis. Although the intrahepatic bile ducts were not significantly dilated on CT scan, LFTs were elevated arousing suspicion of biliary anastomotic stenosis proximal to the Common Bile Duct (CBD). Gadoxetic acid-enhanced MRI was performed to rule out mechanical obstruction. MRCP and DWI showed no bile duct dilatation (Figure 2a ). The Hepatobiliary Phase (HBP) images, after 20 minutes, showed normal CM uptake and excretion in the graft. No narrowing was identified within the biliary tree (Figure 2b ,c). The patient is still alive 12 years after the operation without any complaints.
Case 3
An 11-year-old boy was brought to the ED with low-grade fever and abdominal pain. His medical history was remarkable for a renal and whole LT a year ago for Autosomal Dominant Polycystic Kidney Disease (ADPKD). A few months post-op, he returned with fever and septicemia. An infected bile leak was diagnosed and drained at CT. Eight months after LT, a 2 cm biloma, as well as moderate cholangiectasis were identified on MRCP (Figure 3a ). DWI images showed segmental Figure 3b ). Moreover, the HBP images showed poor uptake and no excretion of CM even after 2 hours post-injection. A revision of the biliary anastomosis was performed. Intra-operative liver biopsy confirmed the diagnosis of cholangitis and progressive cirrhosis. Gadoxetic acid enhanced-MRI performed after revision showed heterogeneous CM uptake but timely excretion via the hepatojejunostomy (Figure 3c ,d). The patient has been fine on tacrolismus since the revision, with normal LFTs.
Case 4
A 6-year-old boy with non metastatichepatoblastoma underwent a living-related LT, segments II-IV from his father's liver serving as the graft. He was placed on Cyclosporineimmunosuppression. At post-op week 5, noncholestatic LFTs were mildly elevated.
Subsequent color Doppler showed no flow in the Hepatic Artery (HA). Emergency CT angiography confirmed the HA occlusion ( Figure 4a ) and also showed multiple hypodense lesions in the liver compatible with ischemic necrosis/biloma. The HA could only be partially recanalized during angiography. Gadoxetic acid enhanced-MRI, 2 months later, showed partial HA stenosis (Figure 4b ). MRCP and DWI, during the same imaging session, showed moderately dilated intrahepatic bile ducts and scattered bilomas in the liver graft, which appeared to be constant (Figure 4c,d) . Additionally, the HBP images showed reduced uptake and delayed excretion of CM in the graft, compatible with graft dysfunction (Figure 4e ). The child was waitlisted for a second LT. Nine months later, he received a reducedsize cadaveric LT of segments I-IV. The most recent MRI, 21 months Submit your Manuscript | www.austinpublishinggroup.com after cadaveric LT, showed normal uptake and excretion on the HBP (Figure 4f ).
Case 5
A 9-year-old boy was brought to the ED with shortness of breath. As an infant he had undergone a Kasai operation for biliary atresia. Admission physical exam was unremarkable except for dyspnea. He was diagnosed with hepatopulmonary syndrome after his blood work showed mildly elevated liver enzymes (noncholestatic and cholestatic). Soon after, he underwent a living donor LT, receiving his father's segments II, III, and IV as a graft. Ten days post-op, he developed thrombocytopenia, and suffered a seizure. A massive intracerebral hematoma, confirmed on CT, was evacuated. During post-op week 2, US done for peritoneal signs, demonstrated portal vein thrombosis and free intraperitoneal fluid. Gadoxetic acid enhanced-MRI, during post-op week 6, showed segmental cholangitis and a giant extra-hepatic fluid collection (Figure 5a,b) . HBP images showed diminished CM uptake and no excretion of the liver graft consistent with severe graft dysfunction (Figure 5c ). A bile leak was confirmed upon puncturing the collection. The patient underwent revision of the biliary anastomosis and correction of the choledochal fistula. Two months post-LT, the patient passed away due to multiple organ failure and massive cerebral hemorrhage caused by hypersplenisminduced thrombocytopenia.
Case 6
A two-year old patient was brought to our ED with confusion. His medical history was remarkable for a diagnosis of citrullinemia type I for which he had undergone liver cell transplantation as a bridge to LT at 9 months old. He underwent a reduced-size LT for hyperammonemia some days later. An auxiliary left lobe was placed beside his preserved right liver lobe. On initial MRI scan, at post-op month 1, both graft and native liver segments showed diminished gadoxetic acid uptake and no excretion on HBP images (Figure 6a ). Moreover mild edema of the auxiliaryliver was noted (Figure 6b ). MRI was again done during post-op month 6 for repeat hyperammonemia. DWI showed edema and cholangiectasis in the left liver graft due to segmental cholangitis. HBP images showed normal CM uptake with delayed excretion in the auxiliary graft but good CM uptake and excretion in the native liver (Figure 6c ). Unfortunately the patient expired from a cardiac arrest. The autopsy report ruled out rejection. 
Case 7
A 6-year-old boy was brought to the ED with drowsiness. Labs showed markedly elevated LFTs, as well as a mild coagulopathy and hyperammonemia accounting for his hepatic encephalopathy. A tru-cut liver biopsy was remarkable for acute liver failure caused by autoimmune hepatitis. The patient immediately underwent a livingrelated auxiliary LT, receiving his father's left lobe where the native right lobe of the patient was preserved. A week post-LT, his ammonia and GGT levels were again elevated. MRI with DWI showed edema in his native right liver lobe (Figure 7a ). Furthermore, dynamic gadoxetic acid imaging was remarkable for hyperemia in the native right liver lobe. Vascular complications were excluded on review of arterial and portal venous phase images (Figure 7b ). Furthermore, CM uptake and excretion on HBP images were absent consistent with severe dysfunction of the native liver. The auxiliary left lobe showed diminished CM uptake and delayed excretion in the HBP suggestive of post-operative delayed function (Figure 7c ). The child was placed on tacrolismus. His course improved dramatically at post-LT month 16, at which time gadoxetic acid enhanced-MRI depicted regular function of both auxiliary and native liver (Figure 7d ). The clinician decided to reduce immunosuppression slowly since the native liver was working again. A follow-up MR at post-op year two, after further immunosuppressant reduction, showed cholangiectasis and diminished function in the auxiliary left lobe (Figure 7e ), likely due to chronic rejection. This rejection was of no clinical concern since the native host liver had good function. In the third post-operative year, immunosupressants were discontinued. Gadoxetic acid enhanced-MRI, at post-op 30 month showed normal function of his native lobe and continued worsening function of the auxiliary lobe (Figure 7f ). Today the patient is alive and well, his LFTs within normal limits.
Discussion/Conclusion
Pediatric LT is the treatment of choice for acute liver failure and end-stage chronic liver disease.Because liver grafts are scarce and LT is exceedingly expensive, close patient follow-up is imperative to give the graft the best chance of survival [8, 9] . Early diagnosis of graft dysfunction, whether acute or chronic, should be made as soon as possible to allow early intervention [10, 11] . Imaging usually begins with Ultrasonography (US) and Doppler, as they are most practical, done at the patient's bedside, in the early post-op period [4, 12, 13] . Suspected vascular complicationsare usually confirmed by CT and/or CT angiography [5, 14, 15] . Biliary complications may be confirmed by CT as well as contrast-enhanced Magnetic Resonance Imaging (MRI) and MRCP [15] . In the pediatric population, conventional MRI would be preferable to CT to avoid ionizing radiation [16] . However, if parenchymal graft dysfunction, i.e. rejection, recurrent disease, is the clinical question, then gadoxetic acid enhanced-MRI would be the exam of choice as it can exclude morphologic complications, such as vascular and biliary disorders, and, detect parenchymal dysfunction simultaneously [17] . In our case series we demonstrated gadoxetic acid's role in evaluation of pre-and post-transplant diagnostic workup. In the first patient, gadoxetic acid-enhanced MRI showed neither uptake nor excretion due to end-stage cholestasis of PSC, but good function after LT, similar to patient 2. Furthermore, gadoxetic acid-enhanced MRI simultaneously depicted both the vascular and biliary structures [cases 3, 4] , as well as graft dysfunction -both global [case 5] and segmental, i.e. auxiliary LT [cases 6, 7] . A variety of different methods for quantitative assessment of global liver function are available, including clearance-retention tests and nuclear medicine methods [18] . Whereas the former serologic tests can not provide data about regional function, the latter technique exposes the patient to radiation and has low spatial resolution.
Gadoxetic acid enhanced-MRI can also help predict liver graft survival, as shown by Wibmer et al. [17] and more recently by Bastati et al [19] . They demonstrated that patients with normal gadoxetic acid uptake and excretion had a 100% probability of one-to three-year re transplantation-free survival, whereas more than half of the patients (in the absence of mechanical bile duct obstruction) with impaired uptake and/or excretion died or had to undergo re-transplantation within one year [17] . These facts show the impact of this noninvasive imaging tool to evaluate structural and/or parenchymal LTassociated complications. These results can be confirmed in our case series. Patients 1 and 2, despite vascular and biliary complications, had good uptake and punctual excretion and thus survived. However patient 4, with poor uptake and excretion had to be re-transplanted due to graft failure.
To understand why gadoxetic acid enhanced-MRI gives us functional information, we consider its pharmacokinetics and how it differs from conventional gadolinium CM. Gadoxetic acidhas extracellular (nonspecific) and intracellular (hepatocyte-specific) features [20], with both renal (50%) and biliary (50%) excretion pathways. The uptake and biliary excretion pathway are mediated through ATP-dependent glutathione-S-transferases, OATP andMRP2/3, respectively [21] . Hepatic uptake and excretion with gadoxetic acid peaks 20 minutes after administration, although it remains within the hepatobiliary system for more than120 minutes [22] . The vast majority of clinical experience with gadoxetic acid is within the adult population [23, 24] . As the pediatric population has distinct pathophysiological processes, all studies-including our recent report-describe the off-label use of gadoxeticacid in those less than 18 years of age. Although, to date, the FDA has not approved its use in children, the large body of literature citing its use in this group suggests that it is safe in children, too [25] [26] [27] [28] [29] . Experience has shown that gadoxetic acid's safety profile is similar to that of other gadolinium-based CM. Furthermore, they have found better diagnostic performanceof gadoxetic acid without a higher incidence of adverse reactions [7, 30, 31] . We can confirm these results in this small cohort and a larger adult cohort of OLT and non-transplant patients examined at our center.
